Fervenza, Fernando C <br/><br/>
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.  [electronic resource] 

 -  The New England journal of medicine  07 2019 
 - 36-46 p.  digital 
<br/><br/> Publication Type: Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1814427  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cyclosporine--adverse effects<br/>Drug Administration Schedule<br/>Female<br/>Glomerulonephritis, Membranous--drug therapy<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Immunosuppressive Agents--adverse effects<br/>Infusions, Intravenous<br/>Intention to Treat Analysis<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Proteinuria--drug therapy<br/>Remission Induction<br/>Rituximab--adverse effects<br/>Treatment Failure<br/>Young Adult